These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
477 related items for PubMed ID: 32350660
1. Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions. Yang X, Dong M, Li S, Chai R, Zhang Z, Li N, Zhang L. Eur Radiol; 2020 Sep; 30(9):4795-4805. PubMed ID: 32350660 [Abstract] [Full Text] [Related]
3. Differentiation of benign from malignant adnexal masses by functional 3 tesla MRI techniques: diffusion-weighted imaging and time-intensity curves of dynamic contrast-enhanced MRI. Malek M, Pourashraf M, Mousavi AS, Rahmani M, Ahmadinejad N, Alipour A, Hashemi FS, Shakiba M. Asian Pac J Cancer Prev; 2015 Sep; 16(8):3407-12. PubMed ID: 25921153 [Abstract] [Full Text] [Related]
4. Intravoxel incoherent motion diffusion-weighted imaging as an adjunct to dynamic contrast-enhanced MRI to improve accuracy of the differential diagnosis of benign and malignant breast lesions. Ma D, Lu F, Zou X, Zhang H, Li Y, Zhang L, Chen L, Qin D, Wang B. Magn Reson Imaging; 2017 Feb; 36():175-179. PubMed ID: 27742437 [Abstract] [Full Text] [Related]
6. Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China. Fan WX, Chen XF, Cheng FY, Cheng YB, Xu T, Zhu WB, Zhu XL, Li GJ, Li S. Medicine (Baltimore); 2018 Jan; 97(4):e9666. PubMed ID: 29369183 [Abstract] [Full Text] [Related]
9. How to manage type 2 curve dilemma in dynamic contrast-enhanced magnetic resonance imaging of the breast: diffusion-weighted imaging or early phase enhancement kinetics? Ulu Öztürk F, Tezcan Ş, Uslu N. Acta Radiol; 2024 Apr; 65(4):341-349. PubMed ID: 38193154 [Abstract] [Full Text] [Related]
10. Diffusion-Weighted Imaging With Apparent Diffusion Coefficient Mapping for Breast Cancer Detection as a Stand-Alone Parameter: Comparison With Dynamic Contrast-Enhanced and Multiparametric Magnetic Resonance Imaging. Pinker K, Moy L, Sutton EJ, Mann RM, Weber M, Thakur SB, Jochelson MS, Bago-Horvath Z, Morris EA, Baltzer PA, Helbich TH. Invest Radiol; 2018 Oct; 53(10):587-595. PubMed ID: 29620604 [Abstract] [Full Text] [Related]
11. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade. Kim KW, Kuzmiak CM, Kim YJ, Seo JY, Jung HK, Lee MS. Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079 [Abstract] [Full Text] [Related]
12. Multiple parameters from ultrafast dynamic contrast-enhanced magnetic resonance imaging to discriminate between benign and malignant breast lesions: Comparison with apparent diffusion coefficient. Cao Y, Wang X, Shi J, Zeng X, Du L, Li Q, Nickel D, Zhou X, Zhang J. Diagn Interv Imaging; 2023 Jun; 104(6):275-283. PubMed ID: 36739225 [Abstract] [Full Text] [Related]
14. Differential diagnosis of nasopharyngeal carcinoma and nasopharyngeal lymphoma based on DCE-MRI and RESOLVE-DWI. Song C, Cheng P, Cheng J, Zhang Y, Sun M, Xie S, Zhang X. Eur Radiol; 2020 Jan; 30(1):110-118. PubMed ID: 31372786 [Abstract] [Full Text] [Related]
15. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy. Zhang M, Horvat JV, Bernard-Davila B, Marino MA, Leithner D, Ochoa-Albiztegui RE, Helbich TH, Morris EA, Thakur S, Pinker K. J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702 [Abstract] [Full Text] [Related]
16. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence. Li Y, Yang Z, Lv W, Qin Y, Tang C, Yan X, Yin T, Ai T, Xia L. Quant Imaging Med Surg; 2023 Sep 01; 13(9):5974-5985. PubMed ID: 37711822 [Abstract] [Full Text] [Related]
17. [The value of synthetic MRI in differential diagnosis of benign and malignant breast lesions]. Che SN, Li J, Xue M, Song Y, Zhao LY, Guo N, Tian Y, Xie LZ, Zhao XM, Zhou CW. Zhonghua Zhong Liu Za Zhi; 2021 Aug 23; 43(8):872-877. PubMed ID: 34407594 [Abstract] [Full Text] [Related]
18. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors. Li T, Yu T, Li L, Lu L, Zhuo Y, Lian J, Xiong Y, Kong D, Li K. J Magn Reson Imaging; 2018 Nov 23; 48(5):1358-1366. PubMed ID: 29717790 [Abstract] [Full Text] [Related]
19. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T. Lo GG, Ai V, Chan JK, Li KW, Cheung PS, Wong TT, Ma M, Lee R, Chien D. J Comput Assist Tomogr; 2009 Nov 23; 33(1):63-9. PubMed ID: 19188787 [Abstract] [Full Text] [Related]